U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2012
595
Name Type Language
PERTUZUMAB
DASH   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Common Name English
RHUMAB-2C4
Code English
PERTUZUMAB [VANDF]
Common Name English
PERTUZUMAB [JAN]
Common Name English
RG-1273
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Common Name English
Pertuzumab [WHO-DD]
Common Name English
PERTUZUMAB [USAN]
Common Name English
PERJETA
Brand Name English
PERTUZUMAB [PURPLE BOOK CDER]
Common Name English
PERTUZUMAB [MART.]
Common Name English
RHUMAB2C4
Code English
RHUMAB 2C4
Code English
pertuzumab [INN]
Common Name English
PERTUZUMAB [MI]
Common Name English
PERTUZUMAB (GENETICAL RECOMBINATION)
JAN  
Official Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 284409
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
WHO-VATC QL01XC13
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
NCI_THESAURUS C155711
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
WHO-ATC L01XC13
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
NDF-RT N0000175661
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
FDA ORPHAN DRUG 400713
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
Code System Code Type Description
INN
8380
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
PRIMARY
LACTMED
Pertuzumab
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
PRIMARY
DRUG CENTRAL
4957
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
PRIMARY
JAPANESE REVIEW
PERJETA
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
PRIMARY APPROVED JUNE 2013
SMS_ID
100000078567
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
PRIMARY
MESH
C485206
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
PRIMARY
DAILYMED
K16AIQ8CTM
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
PRIMARY
ChEMBL
CHEMBL2007641
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
PRIMARY
FDA UNII
K16AIQ8CTM
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
PRIMARY
NCI_THESAURUS
C38692
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
PRIMARY
RXCUI
1298944
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
PRIMARY RxNorm
CAS
380610-27-5
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
PRIMARY
USAN
OO-59
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
PRIMARY
EVMPD
SUB16455MIG
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
PRIMARY
HSDB
8141
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
PRIMARY
WIKIPEDIA
PERTUZUMAB
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
PRIMARY
MERCK INDEX
m8568
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
PRIMARY Merck Index
DRUG BANK
DB06366
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
PRIMARY
IUPHAR
5046
Created by admin on Sat Dec 16 16:41:12 GMT 2023 , Edited by admin on Sat Dec 16 16:41:12 GMT 2023
PRIMARY
ACTIVE MOIETY
PERTUZUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966